Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Radiotracer Lights up PET Scan for Earlier Disease Detection

By HospiMedica International staff writers
Posted on 21 Feb 2024

Most positron emission tomography (PET) imaging systems work by tracing how the body utilizes a radioactive form of glucose for energy. More...

This method is particularly effective for many cancers, as they tend to consume glucose as their primary metabolic fuel, making them easily identifiable on glucose PET scans. However, certain cancers do not primarily use glucose, and some healthy organs like the brain and heart also have high glucose usage, posing challenges in distinguishing some diseases with this imaging technique. Now, scientists have developed a new radiotracer that can map how cells use fructose for energy.

Fructose, commonly referred to as “fruit sugar,” is a different type of metabolic fuel. Found naturally in fruits, honey, and numerous processed foods, fructose is increasingly recognized as a potential fuel source in disease processes. Unlike glucose, fructose is not a standard fuel for the healthy brain and heart, and its use is primarily confined to the liver and kidneys in healthy individuals. The new radiotracer named [18F]4-FDF has been developed by scientists at the University of Ottawa (Ontario, Canada) and can identify areas in the body where fructose is being utilized. This can facilitate the early identification of a wide range of diseases, including various cancers and inflammation in the heart and brain.

The innovative [18F]4-FDF compound is a specially engineered form of fructose and incorporates a radioactive fluorine atom at a key chemical position. This modification enables researchers to monitor the metabolism of fructose within the body. By utilizing PET camera imaging, a standard tool in diagnostic imaging, it is possible to view the increased uptake of fructose by malfunctioning organs and tissues, thus enabling the detection of early signs of inflammation. The development of this fructose-based radiotracer marks a significant advancement, offering new possibilities for earlier detection and treatment of cancers and conditions affecting the brain and heart.

“For the first time, we can see where fructose, a common dietary sugar, is used in the body. Outside of the kidneys and the liver, fructose metabolism in any other organs may point to a sinister problem including cancer and inflammation,” said Professor Adam Shuhendler from uOttawa’s Faculty of Science.

Related Links:
University of Ottawa


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Representative serial optical coherence tomography images of lesion-specific calcium modification. (Image Credit:: Annapoorna S. Kini et al. JACC: Cardiovascular Interventions, 2026. doi:10.1016/j.jcin.2026.10.001)

Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions

Calcified coronary nodules are hard, irregular calcium deposits that protrude into coronary arteries and can complicate percutaneous coronary intervention by preventing full stent expansion.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences

Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.